TrialBlood2007

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Susan P Perrine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.